Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin IT0003828271
Ticker REC.MI
Company RECORDATI
Currency €
Price
Aware Investor Index (AII) 0.0470
Recommendation SELL
P/E 77.77
ROE 13.87 %
Capitalization 10,199,164,760 $
Dividend Yield 1.31 %
P/S 8.96
AII Position 559
P/E Position 701
ROE Position 281
Capitalization Position 495
Dividend Yield Position 462
Sales 1,047,676,000 €
10-Year Average Earnings 120,708,500 €
Shares Outstanding 205,270,094
Equity 869,992,000 €
Dividend per Share 0.6 €
Industry Pharmaceutical
Country Italy
RECORDATI Investor Relations Web Site http://www.recordati.it/it/investors/







Sales:

YEAR MONTH AMOUNT
2015 12 1,047,676,000.00 €
2014 12 987,356,000.00 €
2013 12 941,630,000.00 €

Earnings:

YEAR MONTH AMOUNT
2015 12 198,803,000.00 €
2014 12 161,193,000.00 €
2013 12 133,693,000.00 €
2012 12 118,500,000.00 €
2011 12 116,400,000.00 €
2010 12 108,600,000.00 €
2009 12 110,600,000.00 €
2008 12 100,400,000.00 €
2007 12 84,865,000.00 €
2006 12 74,031,000.00 €

Equity:

YEAR MONTH AMOUNT
2015 12 869,992,000.00 €
2014 12 787,422,000.00 €
2013 12 701,820,000.00 €
2012 12 661,397,000.00 €

Shares Outstanding:

YEAR MONTH AMOUNT
2015 12 205,270,094
2014 12 204,417,486
2013 12 202,615,046
2012 12 200,619,366

 












Bloomberg News for RECORDATI:

Aug 18, 2017
Sidoti & Co. CEO Sees 40 - 50% Less Research Post-MiFID
Peter Sidoti, founder and chief executive officer at Sidoti & Co., discusses the impact of the new MiFID II rules on his firm and across the financial industry. He speaks on "What'd You Miss?"...
Aug 17, 2017
Michigan State Has 15.4% Annual Gain With Boost From Hedge Funds
Michigan State University’s endowment had an investment gain of 15.4 percent in its last fiscal year, thanks to the robust performance of hedge funds.“Our performance was driven by strong returns...
Aug 18, 2017
GM Trust Backs out of Ignition Switch Settlement (Audio)
Erik Gordon, a professor at University of Michigan’s Ross School of Business, discusses how GM thwarted a $15 million settlement between the company’s bankruptcy trust and thousands of plaintiffs...
Aug 15, 2017
UBS Said to Charge $40,000 for Basic MiFID Research
reportedly proposing to charge clients around $40,000 per year to access basic equity research once new MiFID II regulations go into effect next year. Bloomberg's Jason Kelly reports on "Bloomberg Markets:...
Aug 15, 2017
UBS Is Said to Charge About $40,000 for Basic MiFID Research
charge clients about $40,000 a year to access basic equity research once new regulations known as MiFID II come into effect in January, according to people with knowledge of the matter.The research...
Aug 15, 2017
MiFID II Rules and a New Frontier for Banks
The financial industry is preparing for change and making changes ahead of Europe's new MiFID II rules. Bloomberg's Jason Kelly examines the response of the financial industry on "Bloomberg...
Aug 18, 2017
Surge in Expectations Drives Gain in U.S. Consumer Sentiment
one-month advance since the end of 2011, according to University of Michigan survey data released Friday. Highlights of Michigan Sentiment (August, preliminary)Sentiment index rose to 97.6 (est. ...
Aug 14, 2017
Tudor, Brevan Howard Drop MiFID Licenses to Opt Out of New Rules
Investment Corp. and Brevan Howard Asset Management dropped their MiFID licenses, allowing the hedge-fund firms to sidestep Europe’s upcoming MiFID II rules.Both companies secured Alternative Investment...
Aug 14, 2017
MiFID to Cut Back Sell-Side Services, Says Shaoul
officer at Marketfield Asset Management, talks about the potential industry and market impact of MiFID II rules. He speaks on "Bloomberg Daybreak: Americas."...
Aug 15, 2017
The Algo That Entices Fund Managers to Beat MiFID's Trading Caps
yet entered an order.Bloomberg’s Jason Kelly examines Europe’s new MiFID II rules.(Source: Bloomberg)The European Union’s MiFID II overhaul exempts large orders from limits on how much stock trading...


Google News for RECORDATI:

MarketWatch - 21 May 2017
AstraZeneca, Recordati agree Seloken rights deal
LONDON--AstraZeneca PLC (AZN.LN) has entered into an agreement with Recordati S.p.A (REC.MI) for the commercial rights to AstraZeneca's ...
Yahoo Finance - 9 Feb 2017
Edited Transcript of REC.MI earnings conference call or ...
Edited Transcript of REC.MI earnings conference call or .... Here with us today are Mr. Andrea Recordati, Chief Executive Officer and Vice ...
The Pharma Letter (registration) - 13 Apr 2017
Recordati Rare Diseases Canada launched
Recordati Rare Diseases Canada, a company wholly-owned by the Italy-based Recordati Group (REC: MI), will be the exclusive provider of ...
The Pharma Letter (subscription) - 13 Feb 2012
Recordati sales up, despite Zanidip patent loss
Italian drugmaker Recordati (REC: MI) on Friday reported full-year 2011 results, with consolidated revenue reaching 762.0 million euros ...
fabiotroglia.com (Blog) - 21 Jul 2016
Azioni Recordati, la pharma italiana che continua a brillare
Per noi non ci sono limiti per ora, abbiamo acquistato le azioni di Recordati (REC.MI) nel febbraio 2014 a 12 euro, puntavamo come target i 20 ...


Back